Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Clover Biopharmaceuticals Ltd. ( (HK:2197) ) is now available.
Clover Biopharmaceuticals Ltd. has established a Nomination Committee to oversee director appointments, ensuring diversity and independence within its board. This move is part of the company’s governance strategy to enhance operational efficiency and maintain transparency, potentially strengthening its industry position and stakeholder confidence.
More about Clover Biopharmaceuticals Ltd.
Clover Biopharmaceuticals Ltd. is a company incorporated in the Cayman Islands, operating in the biopharmaceutical industry. The company focuses on developing innovative vaccines and biologic therapeutics to address unmet medical needs globally.
Average Trading Volume: 1,252,715
Technical Sentiment Signal: Hold
Current Market Cap: HK$376.1M
For detailed information about 2197 stock, go to TipRanks’ Stock Analysis page.